[1]
G. M. Busetto, “Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature”, AIUA, vol. 91, no. 4, pp. 205-210, Jan. 2020.